Core Viewpoint - The company, Aoxiang Pharmaceutical (603229), is actively expanding its international business presence, focusing on increasing market penetration in Europe, America, Japan, and South Korea [1] Group 1 - The company's products are exported to various countries and regions, including Europe, America, Japan, and South Korea [1] - Aoxiang Pharmaceutical aims to deepen its international business layout [1] - The company is committed to enhancing its international market penetration rate [1]

Core Viewpoint - The company has been exporting products to European Union countries and plans to enhance its international business presence and market penetration [1] Group 1 - The company confirmed that its products are exported to Europe, the United States, Japan, and South Korea [1] - The company aims to deepen its international business layout [1] - The company intends to further increase its international market penetration rate [1]